Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shawn Malone

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
European Urology|April 3, 2024
Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysisSoumyajit Roy, Gagan Fervaha, Daniel E Spratt, et al.
World Journal of Urology|October 18, 2023
Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruptionSteven G Allen, Chao Zhang, Shawn Malone, et al.
International Journal of Radiation Oncology, Biology, Physics|November 17, 2021
Association of Short-Term Patient-Reported Outcomes With Long-Term Oncologic Outcomes in Localized Prostate Cancer Patients Treated With Radiation Therapy and Androgen Deprivation Therapy in a Randomized Controlled TrialSoumyajit Roy, Daniel E Spratt, Scott C Morgan, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Association of dynamic change in patient-reported pain with survival in metastatic castrate sensitive prostate cancer-exploratory analysis of LATITUDE studySoumyajit Roy, Scott C Morgan, Christopher J D Wallis, et al.
The Prostate|April 18, 2023
Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancerSoumyajit Roy, Christopher J D Wallis, Scott C Morgan, et al.
Cancers|October 16, 2024
Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi ConsensusKori Leblanc, Scott J Edwards, George Dranitsaris, et al.
International Journal of Radiation Oncology, Biology, Physics|November 4, 2023
Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A Secondary Analysis of a Phase 3 Randomized Controlled TrialSoumyajit Roy, Shawn Malone, Yilun Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctionsAnthony V D'Amico, James W Denham, Juanita Crook, et al.
The Lancet. Oncology|August 2, 2017
Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trialGillian M Duchesne, Henry H Woo, Madeleine King, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 1, 2019
Management algorithms for metastatic prostate cancerShawn Malone, Bobby Shayegan, Naveen S Basappa, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
European Urology|April 3, 2024
Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysisSoumyajit Roy, Gagan Fervaha, Daniel E Spratt, et al.
World Journal of Urology|October 18, 2023
Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruptionSteven G Allen, Chao Zhang, Shawn Malone, et al.
International Journal of Radiation Oncology, Biology, Physics|November 17, 2021
Association of Short-Term Patient-Reported Outcomes With Long-Term Oncologic Outcomes in Localized Prostate Cancer Patients Treated With Radiation Therapy and Androgen Deprivation Therapy in a Randomized Controlled TrialSoumyajit Roy, Daniel E Spratt, Scott C Morgan, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Association of dynamic change in patient-reported pain with survival in metastatic castrate sensitive prostate cancer-exploratory analysis of LATITUDE studySoumyajit Roy, Scott C Morgan, Christopher J D Wallis, et al.
The Prostate|April 18, 2023
Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancerSoumyajit Roy, Christopher J D Wallis, Scott C Morgan, et al.
Cancers|October 16, 2024
Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi ConsensusKori Leblanc, Scott J Edwards, George Dranitsaris, et al.
International Journal of Radiation Oncology, Biology, Physics|November 4, 2023
Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A Secondary Analysis of a Phase 3 Randomized Controlled TrialSoumyajit Roy, Shawn Malone, Yilun Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctionsAnthony V D'Amico, James W Denham, Juanita Crook, et al.
The Lancet. Oncology|August 2, 2017
Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trialGillian M Duchesne, Henry H Woo, Madeleine King, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 1, 2019
Management algorithms for metastatic prostate cancerShawn Malone, Bobby Shayegan, Naveen S Basappa, et al.
Pageof 12